SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-20-002580
Filing Date
2020-04-27
Accepted
2020-04-24 21:19:09
Documents
125
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2241359z20-f.htm 20-F 2185579
2 EX-12.1 a2241359zex-12_1.htm EX-12.1 14254
3 EX-12.2 a2241359zex-12_2.htm EX-12.2 13487
4 EX-13.1 a2241359zex-13_1.htm EX-13.1 7619
5 EX-13.2 a2241359zex-13_2.htm EX-13.2 7258
12 G1008035.JPG g1008035.jpg GRAPHIC 50849
13 G447881.JPG g447881.jpg GRAPHIC 53879
14 G43711.JPG g43711.jpg GRAPHIC 53731
15 G606221.JPG g606221.jpg GRAPHIC 47532
16 G945779.JPG g945779.jpg GRAPHIC 39626
17 G507716.JPG g507716.jpg GRAPHIC 34170
18 G836255.JPG g836255.jpg GRAPHIC 39247
19 G820505.JPG g820505.jpg GRAPHIC 28080
20 G942672.JPG g942672.jpg GRAPHIC 38241
21 G627713.JPG g627713.jpg GRAPHIC 70351
22 G924986.JPG g924986.jpg GRAPHIC 68002
23 G585378.JPG g585378.jpg GRAPHIC 29390
24 G134990.JPG g134990.jpg GRAPHIC 23749
  Complete submission text file 0001047469-20-002580.txt   12203526

Data Files

Seq Description Document Type Size
6 EX-101.INS adxn-20191231.xml EX-101.INS 3121515
7 EX-101.SCH adxn-20191231.xsd EX-101.SCH 104868
8 EX-101.CAL adxn-20191231_cal.xml EX-101.CAL 69490
9 EX-101.DEF adxn-20191231_def.xml EX-101.DEF 269177
10 EX-101.LAB adxn-20191231_lab.xml EX-101.LAB 649866
11 EX-101.PRE adxn-20191231_pre.xml EX-101.PRE 510654
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-39179 | Film No.: 20816974
SIC: 2834 Pharmaceutical Preparations